Intercept to Present at Upcoming Conference

World News: . []

NEW YORK, March 13, 2018 (GLOBE NEWSWIRE) --

Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced management will be participating in the following investor conference:

Webcast information for this event will be available on the Investors page of Intercept's website at . Archived webcasts will be available on  Intercept's website for approximately two weeks.

CONTACT: For more information about Intercept Pharmaceuticals, please contact:

Intercept Pharmaceuticals:Mark Vignola+1-646-747-1000 

Media inquiries:  

Investor inquiries:  

More news and information about Intercept Pharmaceuticals, Inc.

Published By:

Globe Newswire: 21:00 GMT Tuesday 13th March 2018

Published: .

Search for other references to "intercept" on SPi News

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
Privacy Policy | Terms and Conditions | Contact Us

Advertising on SPi News: Information For Advertisers